Seven Star Pharmaceutical Services

What Seven Star Pharmaceutical Services does

Seven Star Pharmaceutical Services is a privately held contract research organization (CRO) founded in 2018 and headquartered in Malvern, Pennsylvania, with a secondary office in Wilmington, Delaware. The firm serves pharmaceutical and biotechnology clients with specialized chemistry, analytical, and formulation development services. Its service portfolio centers on solid-state chemistry, polymorph screening, co-crystal design and screening (including a proprietary CAB-based co-crystal methodology), crystallization process development, analytical method development and validation, preformulation studies, and formulation development, with extended capabilities in spray drying and lyophilization.

The company's technical differentiation rests on the deep specialization of its founder and advisory bench in solid-state pharmaceutical sciences. Founder Sathyanarayana Reddy Perumalla, Ph.D., brings 15+ years of industry experience, including a tenure at Teva Pharmaceuticals, and is supported by an advisory board drawing senior executives from Tyra Biosciences, Teva, Cephalon, Esperion, NewLink Genetics, and Iovance Biotherapeutics. The team collectively accounts for 100+ patents and peer-reviewed publications and reports hands-on experience screening more than 500 compounds.

The business model is project-based fee-for-service work typical of boutique CROs. Revenue is generated per project through defined scopes of work spanning solid form screening, crystallization development, analytical testing, and formulation support. The firm operates with a small employee base of 1-10 and has not disclosed any external funding rounds, suggesting it is funded organically through operating cash flow. Marketing efforts include a Knowledge Hub content platform positioning the firm as a thought leader in solid-state chemistry, used to support inbound business development from pharma and biotech sponsors.

Name

Seven Star Pharmaceutical Services

Legal name

Seven Star Pharmaceutical Services

Website

https://sevenstarpharm.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Seven Star Pharmaceutical Services is a privately held CRO founded in 2018 in Malvern, PA, providing solid-state chemistry, crystallization, analytical, and formulation development services to pharmaceutical and biotechnology clients.

Ownership category

akta.pro rank

Product category

Pharmaceutical CRO Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)

akta.pro secondary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Solid form screening
• Crystallization process development
• Pharmaceutical analytical testing
• Preformulation development
• CMC consulting services

Headquarters

HQ city

Malvern

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Contract Research Services: Seven Star generates revenue through project-based professional services contracts with pharmaceutical and biotech companies. Services include solid form screening, crystallization development, analytical testing, and formulation support. Contracts are typically custom engagements based on client drug development needs, with pricing determined by project scope, complexity, and turnaround requirements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Seven Star Pharmaceutical Services is a contract research organization (CRO) providing solid-state chemistry, crystallization, and analytical testing services to pharmaceutical and biotech companies. Core offerings include solid form screening and selection, crystallization process development, preformulation and formulation development, intellectual property support, and an extensive analytical testing portfolio spanning X-ray diffraction, thermal analysis, chromatography, spectroscopy, and particle characterization. Services are delivered through project-based professional services contracts from laboratories in Pennsylvania and Delaware.

Product overview

Seven Star Pharmaceutical Services is a contract research organization (CRO) offering a comprehensive suite of pharmaceutical development and analytical testing services. The company's core offerings include solid form screening and selection, crystallization process development, and preformulation/formulation development services. Supporting these core services is an extensive portfolio of routine analytical testing capabilities covering X-ray diffraction (both single crystal and powder), thermal analysis (TGA, DSC), chromatography (HPLC), spectroscopy (FTIR, Raman), particle characterization, and physical testing services. The company serves pharmaceutical and biotech clients requiring CMC development support, intellectual property characterization, and quality control testing throughout drug development.

Differentiator

Problem solved

Functional benefit

Products and services

• Solid Form Screening and Selection Expert solid-state chemistry and crystallography services that identify and select optimal solid forms (polymorphs, salts, co-crystals) for pharmaceutical drug development, supporting regulatory compliance and IP protection.
• Crystallization Process Development Development and optimization of crystallization processes for pharmaceutical compounds to enable scalable, reproducible, and cost-effective manufacturing.
• Intellectual Property Support Services IP-related CRO support including patent protection for new polymorphs, solid form characterization for IP purposes, and expert services tied to pharmaceutical intellectual property.
• Preformulation & Formulation Development Early-stage pharmaceutical development services including preformulation studies and formulation development for drug products.
• Spray Drying Services Particle engineering via spray drying to improve pharmaceutical stability and bioavailability.
• Lyophilization / Freeze-Drying Services Low-temperature dehydration process for preserving heat-sensitive pharmaceutical materials, performed using Buchi's Lyovapor L-200 Pro Control freeze dryer.
• Analytical Development Comprehensive analytical method development and validation services supporting pharmaceutical testing throughout drug development.
• Pharmaceutical Stability Testing Stability studies to evaluate shelf life and performance of pharmaceutical formulations.
• X-ray Powder Diffraction (XRPD) Testing Powder X-ray diffraction analysis used to identify crystalline forms and polymorphs in pharmaceutical samples.
• Thermogravimetric Analysis (TGA) Thermal analysis measuring weight changes as a function of temperature to identify desolvation or decomposition processes in pharmaceutical samples.
• Differential Scanning Calorimetry (DSC) Thermal analysis measuring heat flow differences between a sample and reference to detect melting, crystallization, glass transitions, and phase transitions.
• Dynamic Vapor Sorption (DVS) Moisture sorption analysis characterizing hygroscopicity and stability of pharmaceutical materials under varying humidity conditions.
• Particle Size Analysis (Mastersizer 3000) Laser diffraction-based particle size distribution analysis using the Mastersizer 3000 system.
• Gas Pycnometer Density Measurement True density measurement of solid pharmaceutical materials using gas displacement technique.
• FT4 Powder Rheometer Services Powder flow characterization and rheological properties analysis using the FT4 powder rheometer.
• Dissolution Testing

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature12 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• SGS Life Sciences: Global testing and laboratory services provider with pharmaceutical analytical, stability, and formulation support capabilities that overlap with Seven Star's routine analytical testing services.
• Eurofins Scientific: Large contract laboratory network offering extensive pharmaceutical analytical testing, formulation support, and CMC-related services globally — competitive with Seven Star's routine analytical and stability testing menu.
• Thermo Fisher Scientific (PPD): Global CRO and CDMO with extensive pharmaceutical development services including solid form, formulation, and analytical testing, serving as a full-service alternative to specialized CROs.
• Charles River Laboratories: Large CRO providing discovery, preclinical, and CMC services including formulation and analytical development. A broad incumbent whose offerings overlap with Seven Star's preformulation and analytical testing menu.
• WuXi AppTec: Global CRO/CDMO offering a much broader set of services including solid form, formulation, and analytical testing. Competes for the same pharma R&D budgets as Seven Star but as a full-service incumbent.
• Intertek Pharmaceutical Services: Pharmaceutical contract laboratory offering analytical development, stability testing, and formulation support — competing for the same pharma QC and CMC testing budgets as Seven Star.

Direct peers

• Alcami Corporation: CDMO/CRO offering solid form services, preformulation, analytical development, and stability testing for pharmaceutical clients — a comparable mid-sized CRO peer.
• AMRI (Curia): Contract development and manufacturing organization offering API development, solid form services, preformulation, and analytical testing for small molecule pharma — overlapping significantly with Seven Star's CMC and analytical services.
• SSCI (Solid State Chemical Information): A CRO specializing in solid-state chemistry, polymorphism screening, crystallization development, and analytical services for the pharmaceutical industry — the closest direct competitor to Seven Star in niche, customer base, and service offering.
• Aptuit (an Evotec company): CMC-focused CRO providing preformulation, solid form selection, and analytical development services to pharma and biotech. Directly comparable in service portfolio for small-molecule drug development support.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/seven-star-pharmaceutical-services
• Facebookfacebook.com/Seven-Star-Pharmaceutical-Services-61570120107569

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Seven Star Pharmaceutical Services